ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Aneurysm ruptured,Aneurysms and dissections non-site specific,Aneurysms and artery dissections,Vasc,N
1,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1,3,Haemorrhagic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
4,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5,3,Headache,Headaches NEC,Headaches,Nerv,N
5,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6,3,Renal cancer metastatic,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,Y
7,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
7,2,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
8,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
9,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
10,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
11,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
12,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
12,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
13,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
14,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
15,1,Genital herpes,Herpes viral infections,Viral infectious disorders,Infec,N
16,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
16,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
16,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
17,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
17,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
18,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
18,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
18,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
18,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
19,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
19,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
19,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
20,1,Precancerous cells present,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
21,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
22,1,Pre-existing condition improved,General signs and symptoms NEC,General system disorders NEC,Genrl,N
22,2,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
23,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
24,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
25,1,Headache,Headaches NEC,Headaches,Nerv,N
25,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
25,3,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
25,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
26,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
26,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
26,3,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
27,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
28,1,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
29,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
30,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
31,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
31,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
31,3,General symptom,General signs and symptoms NEC,General system disorders NEC,Genrl,N
31,4,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
32,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
32,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
32,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
32,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
33,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
33,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
33,3,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
33,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
34,1,Epicondylitis,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
34,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
34,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
34,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
34,5,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
34,6,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
34,7,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
35,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
36,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
37,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
37,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
38,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
39,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
39,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
40,1,Headache,Headaches NEC,Headaches,Nerv,N
41,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
41,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
41,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
42,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
43,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
44,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
44,2,Multimorbidity,General signs and symptoms NEC,General system disorders NEC,Genrl,N
44,3,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
45,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
45,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
46,1,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
46,2,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
47,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
48,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
48,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
48,3,Headache,Headaches NEC,Headaches,Nerv,N
48,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
48,5,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
49,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
50,1,Intervertebral disc disorder,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
50,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
51,1,Gouty tophus,Crystal arthropathic disorders,Joint disorders,Musc,N
52,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
53,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
54,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
54,2,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
54,3,Perineal abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
54,4,Perineal disorder,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
54,5,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
54,6,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
54,7,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
54,8,Vulval disorder,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
55,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
56,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
57,1,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
58,1,Enterostomy,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
58,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
58,3,Ileostomy,Small intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
58,4,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
59,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
59,2,Headache,Headaches NEC,Headaches,Nerv,N
59,3,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
60,1,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
61,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
62,1,Acne,Acnes,Skin appendage conditions,Skin,N
62,2,Hypomenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
63,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
64,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
64,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
65,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
65,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
66,1,Headache,Headaches NEC,Headaches,Nerv,N
67,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
67,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
68,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
68,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
69,1,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
70,1,Erythema annulare,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
70,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
70,3,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
70,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
70,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
70,6,Tinea infection,Tinea infections,Fungal infectious disorders,Infec,N
70,7,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
71,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
72,1,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
72,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
73,1,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
74,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
74,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
75,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
75,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
75,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
76,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
77,1,Lipids increased,Lipoprotein and lipid tests NEC,Lipid analyses,Inv,N
78,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
79,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
80,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
80,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
81,1,Alanine aminotransferase decreased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
82,1,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
82,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
83,1,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
84,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
85,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
85,2,Eczema infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
85,3,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
86,1,Genital rash,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
86,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
86,3,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
87,1,Acne,Acnes,Skin appendage conditions,Skin,N
87,2,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
88,1,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
89,1,Headache,Headaches NEC,Headaches,Nerv,N
90,1,Bladder irritation,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
90,2,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
90,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
91,1,Bladder irritation,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
91,2,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
91,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
91,4,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
91,5,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
91,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
92,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
93,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
94,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
94,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
95,1,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
96,1,C-reactive protein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
96,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
96,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
96,4,Red blood cell sedimentation rate abnormal,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
97,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
98,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
99,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
100,1,Acne,Acnes,Skin appendage conditions,Skin,N
101,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
101,2,Headache,Headaches NEC,Headaches,Nerv,N
101,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
102,1,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
102,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
103,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
104,1,Expulsion of medication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
105,1,Neuroendocrine carcinoma metastatic,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
106,1,Hepatic cancer metastatic,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
107,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
108,1,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
109,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
110,1,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
111,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
111,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
111,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
111,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
112,1,Fracture delayed union,Fracture complications,Fractures,Musc,N
113,1,Headache,Headaches NEC,Headaches,Nerv,N
114,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
114,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
115,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
115,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
116,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
117,1,Acne,Acnes,Skin appendage conditions,Skin,N
117,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
117,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
117,4,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
117,5,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
117,6,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
118,1,Adrenal mass,Adrenal gland disorders NEC,Adrenal gland disorders,Endo,N
119,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
120,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
120,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
120,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
121,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
121,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
122,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
123,1,Headache,Headaches NEC,Headaches,Nerv,N
124,1,Abnormal sensation in eye,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
124,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
124,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
124,4,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
124,5,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
124,6,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
124,7,Eyelid irritation,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
124,8,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
124,9,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
125,1,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
126,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
127,1,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
127,2,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
127,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
128,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
128,2,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
129,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
130,1,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
130,2,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
131,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
131,2,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
131,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
132,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
132,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
133,1,Acne,Acnes,Skin appendage conditions,Skin,N
133,2,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
134,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
134,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
134,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
134,4,Headache,Headaches NEC,Headaches,Nerv,N
134,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
135,1,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
136,1,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
137,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
137,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
137,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
138,1,Acne,Acnes,Skin appendage conditions,Skin,N
138,2,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
138,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
138,4,Inflammation,Inflammations,General system disorders NEC,Genrl,N
138,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
138,6,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
138,7,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
139,1,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
139,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
140,1,Alopecia totalis,Alopecias,Skin appendage conditions,Skin,N
140,2,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
141,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
141,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
141,3,Eyelid oedema,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
142,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
143,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
144,1,Acne,Acnes,Skin appendage conditions,Skin,N
145,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
146,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
147,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
147,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
148,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
148,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
148,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
148,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
148,5,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
149,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
150,1,Acne,Acnes,Skin appendage conditions,Skin,N
150,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
150,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
151,1,Acne,Acnes,Skin appendage conditions,Skin,N
152,1,Acne,Acnes,Skin appendage conditions,Skin,N
152,2,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
153,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
154,1,Acne,Acnes,Skin appendage conditions,Skin,N
155,1,Migraine,Migraine headaches,Headaches,Nerv,N
156,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
157,1,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
158,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
158,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
159,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
159,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
159,3,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
159,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
160,1,Expulsion of medication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
161,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
162,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
163,1,Macrocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
164,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
165,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
165,2,Drug tolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
166,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
166,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
166,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
167,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
168,1,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
168,2,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
168,3,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
169,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
169,2,Change of bowel habit,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
170,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
170,2,Mean cell volume increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
170,3,Red blood cell abnormality,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
171,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
171,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
171,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
172,1,Acne,Acnes,Skin appendage conditions,Skin,N
173,1,Acne,Acnes,Skin appendage conditions,Skin,N
173,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
174,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
175,1,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
176,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
177,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
178,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
179,1,Localised oedema,Oedema NEC,General system disorders NEC,Genrl,N
179,2,Seasonal allergy,Atopic disorders,Allergic conditions,Immun,N
180,1,Acne,Acnes,Skin appendage conditions,Skin,N
181,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
181,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
181,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
181,4,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
181,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
181,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
181,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
181,8,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
182,1,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
182,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
183,1,Embolism venous,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
183,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
184,1,Drug clearance increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
185,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
186,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
187,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
188,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
189,1,Blood creatine phosphokinase abnormal,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
190,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
191,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
191,2,Headache,Headaches NEC,Headaches,Nerv,N
191,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
192,1,Axillary pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
192,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
193,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
193,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
194,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
194,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
195,1,Acne,Acnes,Skin appendage conditions,Skin,N
196,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
196,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
196,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
196,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
197,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
197,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
198,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
199,1,Sacroiliitis,Arthropathies NEC,Joint disorders,Musc,N
199,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
200,1,Acne,Acnes,Skin appendage conditions,Skin,N
200,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
200,3,Faecal calprotectin increased,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
201,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
202,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
203,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
204,1,Acne,Acnes,Skin appendage conditions,Skin,N
205,1,Acne,Acnes,Skin appendage conditions,Skin,N
205,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
205,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
205,4,Faecal calprotectin increased,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
206,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
207,1,Lacunar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
208,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
208,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
208,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
208,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
208,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
209,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
210,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
211,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
212,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
213,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
214,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
215,1,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
216,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
216,2,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
216,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
217,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
217,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
217,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
217,4,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
217,5,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
217,6,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
217,7,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
217,8,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
217,9,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
217,10,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
217,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
217,12,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
217,13,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
217,14,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
217,15,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
218,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
219,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
219,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
220,1,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
221,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,Y
222,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
223,1,Nasal inflammation,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
224,1,Stoma care,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
225,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
226,1,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
227,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
227,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
227,3,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
227,4,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
228,1,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
229,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
229,2,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
230,1,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
231,1,Headache,Headaches NEC,Headaches,Nerv,N
232,1,Thrombocytosis,Thrombocytoses,Platelet disorders,Blood,N
233,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
233,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
234,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
234,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
235,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
236,1,Acne,Acnes,Skin appendage conditions,Skin,N
237,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
238,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
239,1,Acne,Acnes,Skin appendage conditions,Skin,N
240,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
241,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
241,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
242,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
243,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
244,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
245,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
245,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
245,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
246,1,Parotitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
247,1,Stoma obstruction,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
248,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
248,2,Ileostomy,Small intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
248,3,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
248,4,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
248,5,Stoma site pain,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
248,6,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
249,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
250,1,Headache,Headaches NEC,Headaches,Nerv,N
251,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
251,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
251,3,Localised oedema,Oedema NEC,General system disorders NEC,Genrl,N
251,4,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
251,5,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
251,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
251,7,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
251,8,Parotitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
251,9,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
251,10,Trismus,Muscle tone abnormalities,Muscle disorders,Musc,N
252,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
253,1,Migraine,Migraine headaches,Headaches,Nerv,N
253,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
254,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
254,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
254,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
254,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
255,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
256,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
257,1,Stoma care,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
258,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
259,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
259,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
259,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
259,4,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
259,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
260,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
261,1,Portal vein thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
262,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
263,1,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
264,1,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
265,1,Parotitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
266,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
267,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
268,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
269,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
269,2,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
269,3,Headache,Headaches NEC,Headaches,Nerv,N
269,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
270,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
271,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
271,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
271,3,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
271,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
271,5,Myocarditis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
272,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
273,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
274,1,Embolism venous,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
274,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
275,1,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
276,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
276,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
276,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
277,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
278,1,Acne,Acnes,Skin appendage conditions,Skin,N
278,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
279,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
279,2,Migraine,Migraine headaches,Headaches,Nerv,N
279,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
280,1,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
281,1,Infected cyst,Infections NEC,Infections - pathogen unspecified,Infec,N
282,1,Acne,Acnes,Skin appendage conditions,Skin,N
283,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
284,1,Nail bed bleeding,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
284,2,Nail bed tenderness,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
284,3,Onycholysis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
285,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
286,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
286,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
287,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
287,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
287,3,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
287,4,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
287,5,Gastrointestinal stoma complication,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
287,6,Gastrointestinal stoma complication,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
287,7,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
287,8,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
287,9,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
287,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
287,11,Stoma creation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
287,12,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
288,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
289,1,Acne,Acnes,Skin appendage conditions,Skin,N
289,2,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
290,1,Full blood count,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
290,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
291,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
291,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
291,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
292,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
292,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
293,1,Acne,Acnes,Skin appendage conditions,Skin,N
294,1,Acne,Acnes,Skin appendage conditions,Skin,N
295,1,Product solubility abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
296,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
297,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
298,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
298,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
299,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
299,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
299,3,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
300,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
300,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
301,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
302,1,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
302,2,Stoma creation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
302,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
303,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
303,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
303,3,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
303,4,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
304,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
304,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
304,3,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
304,4,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
305,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
305,2,Acne cystic,Acnes,Skin appendage conditions,Skin,N
305,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
305,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
305,5,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
305,6,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
305,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
305,8,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
305,9,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
305,10,Myalgia,Muscle pains,Muscle disorders,Musc,N
305,11,Oligomenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
305,12,Premenstrual syndrome,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
305,13,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
306,1,Diverticular perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
306,2,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
307,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
307,2,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
307,3,Gingival ulceration,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
307,4,Lip ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
307,5,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
307,6,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
307,7,Oral mucosal eruption,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
307,8,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
308,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
309,1,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
310,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
311,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
311,2,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
312,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
313,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
314,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
315,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
315,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
315,3,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
315,4,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
316,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
316,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
317,1,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
318,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
319,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
320,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
321,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
322,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
323,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
324,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
324,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
325,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
325,2,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
325,3,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
326,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
326,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
326,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
327,1,Acne,Acnes,Skin appendage conditions,Skin,N
328,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
329,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
330,1,Headache,Headaches NEC,Headaches,Nerv,N
330,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
331,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
332,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
333,1,Acne,Acnes,Skin appendage conditions,Skin,N
334,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
335,1,Headache,Headaches NEC,Headaches,Nerv,N
335,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
336,1,Genital hypoaesthesia,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
337,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
338,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
339,1,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
340,1,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
341,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
342,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
342,2,Small intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
343,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
343,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
344,1,Acne,Acnes,Skin appendage conditions,Skin,N
345,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
345,2,Acne,Acnes,Skin appendage conditions,Skin,N
345,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
345,4,Dyschezia,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
346,1,Extradural abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
346,2,Lung abscess,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
347,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
348,1,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
349,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
350,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
351,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
352,1,Acne,Acnes,Skin appendage conditions,Skin,N
353,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
353,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
354,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
355,1,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
356,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
356,2,Costochondritis,Cartilage disorders,"Tendon, ligament and cartilage disorders",Musc,N
356,3,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
356,4,Painful respiration,Respiratory signs and symptoms NEC,Respiratory tract signs and symptoms,Resp,N
356,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
357,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
358,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
358,2,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
358,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
359,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
359,2,Granuloma,Inflammations,General system disorders NEC,Genrl,N
359,3,Hilar lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
359,4,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
360,1,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
361,1,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
362,1,Cardiac flutter,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
362,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
362,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
362,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
363,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
363,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
364,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
365,1,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
365,2,Headache,Headaches NEC,Headaches,Nerv,N
365,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
366,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
367,1,Nail avulsion,Skin injuries NEC,Injuries NEC,Inj&P,N
368,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
368,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
368,3,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
369,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
369,2,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
370,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
370,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
370,3,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
371,1,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
372,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
373,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
374,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
374,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
374,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
374,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
374,5,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
374,6,Diverticulitis intestinal perforated,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
374,7,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
374,8,Fluid intake reduced,Fluid intake decreased,Electrolyte and fluid balance conditions,Metab,N
374,9,Gastric perforation,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
374,10,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
374,11,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
374,12,Inflammation,Inflammations,General system disorders NEC,Genrl,N
374,13,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
374,14,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
374,15,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
375,1,Acne,Acnes,Skin appendage conditions,Skin,N
375,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
376,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
376,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
376,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
377,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
378,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
379,1,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
380,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
381,1,Acne,Acnes,Skin appendage conditions,Skin,N
382,1,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
382,2,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
383,1,Non-high-density lipoprotein cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
384,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
384,2,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
385,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
385,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
385,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
385,4,Intestinal transit time decreased,Gastrointestinal and abdominal imaging procedures,Gastrointestinal investigations,Inv,N
385,5,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
385,6,Spondyloarthropathy,Spondyloarthropathies,Joint disorders,Musc,N
385,7,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
386,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
387,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
387,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
388,1,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
389,1,Deafness,Hearing losses,Hearing disorders,Ear,N
389,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
390,1,Reflux gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
391,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
392,1,Herpes ophthalmic,Herpes viral infections,Viral infectious disorders,Infec,N
392,2,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
393,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
394,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
395,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
395,2,Semen discolouration,Spermatogenesis and semen disorders,Sexual function and fertility disorders,Repro,N
396,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
397,1,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
398,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
399,1,Brain stem stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
399,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
399,3,Headache,Headaches NEC,Headaches,Nerv,N
399,4,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
400,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
401,1,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
402,1,Anal fissure,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
402,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
403,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
404,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
405,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
405,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
405,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
405,4,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
406,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
406,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
406,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
406,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
407,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
407,2,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
407,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
407,4,Headache,Headaches NEC,Headaches,Nerv,N
407,5,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
407,6,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
408,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
408,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
408,3,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
408,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
408,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
408,6,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
408,7,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
408,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
408,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
408,10,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
408,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
409,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
409,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
410,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
411,1,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
412,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
413,1,Allergy to chemicals,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
413,2,Headache,Headaches NEC,Headaches,Nerv,N
414,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
414,2,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
415,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
415,2,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
416,1,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
417,1,Eyelid pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
417,2,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
418,1,Acne,Acnes,Skin appendage conditions,Skin,N
418,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
418,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
418,4,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
418,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
418,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
418,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
418,8,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
419,1,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
420,1,Hydrocele,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
421,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
422,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
423,1,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
423,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
424,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
425,1,Migraine,Migraine headaches,Headaches,Nerv,N
426,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
426,2,General symptom,General signs and symptoms NEC,General system disorders NEC,Genrl,N
427,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
428,1,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
429,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
429,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
430,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
431,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
432,1,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
433,1,Blood creatine phosphokinase,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
434,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
435,1,Acne,Acnes,Skin appendage conditions,Skin,N
436,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
436,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
436,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
437,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
437,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
437,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
437,4,Headache,Headaches NEC,Headaches,Nerv,N
438,1,Herpes ophthalmic,Herpes viral infections,Viral infectious disorders,Infec,N
439,1,Colostomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
439,2,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
440,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
441,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
442,1,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
443,1,Skin hypopigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
444,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
445,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
445,2,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
445,3,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
446,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
447,1,Thrombotic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
448,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
448,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
448,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
448,4,Narcolepsy,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
448,5,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
449,1,Corneal scar,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
449,2,Herpes ophthalmic,Herpes viral infections,Viral infectious disorders,Infec,N
449,3,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
449,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
450,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
451,1,Headache,Headaches NEC,Headaches,Nerv,N
451,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
452,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
453,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
453,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
454,1,Blood triglycerides abnormal,Triglyceride analyses,Lipid analyses,Inv,N
454,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
455,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
456,1,Erythrodermic atopic dermatitis,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
456,2,Herpes ophthalmic,Herpes viral infections,Viral infectious disorders,Infec,N
457,1,Gastric perforation,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
458,1,Obstruction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
459,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
460,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
461,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
462,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
462,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,Y
463,1,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
463,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
464,1,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
465,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
465,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
466,1,Acne,Acnes,Skin appendage conditions,Skin,N
467,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
467,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
468,1,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
468,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
469,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
469,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
470,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
470,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
471,1,Clear cell renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
472,1,Acne,Acnes,Skin appendage conditions,Skin,N
473,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
473,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
473,3,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
473,4,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
473,5,Renal function test abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
473,6,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
474,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
474,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
475,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
476,1,Acne,Acnes,Skin appendage conditions,Skin,N
476,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
477,1,Acne,Acnes,Skin appendage conditions,Skin,N
478,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
479,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
480,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
481,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
481,2,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
482,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
483,1,Semen discolouration,Spermatogenesis and semen disorders,Sexual function and fertility disorders,Repro,N
484,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
485,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
486,1,Acne,Acnes,Skin appendage conditions,Skin,N
487,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
488,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
488,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
488,3,Headache,Headaches NEC,Headaches,Nerv,N
488,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
488,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
489,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
490,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
490,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
491,1,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
492,1,Headache,Headaches NEC,Headaches,Nerv,N
493,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
494,1,Small intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
495,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
496,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
496,2,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
497,1,Embolism venous,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
498,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
498,2,Herpes zoster reactivation,Herpes viral infections,Viral infectious disorders,Infec,N
499,1,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
499,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
500,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
501,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
501,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
501,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
501,4,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
501,5,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
502,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
502,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
503,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
504,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
505,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
505,2,Low density lipoprotein increased,Cholesterol analyses,Lipid analyses,Inv,N
506,1,C-reactive protein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
506,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
506,3,Genital herpes,Herpes viral infections,Viral infectious disorders,Infec,N
507,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
507,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
508,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
508,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
509,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
509,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
510,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
510,2,Localised oedema,Oedema NEC,General system disorders NEC,Genrl,N
511,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
512,1,Learning disorder,Learning disorders,Cognitive and attention disorders and disturbances,Psych,N
513,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
513,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
513,3,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
514,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
515,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
515,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
516,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
517,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
517,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
518,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
519,1,Ophthalmic herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
520,1,Lipids increased,Lipoprotein and lipid tests NEC,Lipid analyses,Inv,N
521,1,Acne,Acnes,Skin appendage conditions,Skin,N
